Kontakt.io vs Pfizer

Side-by-side comparison of AI visibility scores, market position, and capabilities

Pfizer leads in AI visibility (93 vs 72)
Kontakt.io logo

Kontakt.io

LeaderHealthcare

Hospital Operations & Real-Time Location Systems

Kontakt.io is the leading AI-powered RTLS platform for healthcare, providing real-time location and care orchestration for hospitals; SOC 2 and HIPAA certified; launched Patient Flow AI and Access Agent in 2025.

AI VisibilityBeta
Overall Score
B72
Category Rank
#111 of 596
AI Consensus
79%
Trend
stable
Per Platform
ChatGPT
74
Perplexity
77
Gemini
74

About

Kontakt.io is a healthcare technology company that provides an AI-powered Real-Time Location System (RTLS) and care operations platform for hospitals and health systems. Founded in 2013 in Krakow, Poland, and expanded to the U.S. market, Kontakt.io helps hospitals track assets, staff, and patients in real time to improve operational efficiency, reduce length of stay, enhance patient safety, and streamline workflows across inpatient, ICU, emergency, and procedural care settings.

Full profile
Pfizer logo

Pfizer

LeaderHealthcare Tech

Enterprise

Global biopharma with $63.6B FY2024 revenue; $43B Seagen ADC acquisition rebuilds post-COVID pipeline; patent cliff 2026-2028 for Eliquis; activist Starboard Value pushing restructuring.

AI VisibilityBeta
Overall Score
A93
Category Rank
#1 of 596
AI Consensus
80%
Trend
stable
Per Platform
ChatGPT
94
Perplexity
89
Gemini
94

About

Pfizer is one of the world's largest biopharmaceutical companies, founded in 1849 by cousins Charles Pfizer and Charles Erhart in Brooklyn, New York, and now headquartered in New York City. The company trades on NYSE (PFE) and reported $63.6 billion in total revenues for FY2024, normalizing from pandemic highs of $100 billion-plus in 2021-2022 driven by Comirnaty COVID-19 vaccine revenues with BioNTech and Paxlovid COVID antiviral sales. CEO Albert Bourla has led a strategic pivot to reset the company's long-term growth profile, anchored by the landmark $43 billion acquisition of Seagen in December 2023, adding a world-class antibody-drug conjugate (ADC) oncology pipeline including Padcev, Tukysa, Adcetris, and Tivdak.

Full profile

AI Visibility Head-to-Head

72
Overall Score
93
#111
Category Rank
#1
79
AI Consensus
80
stable
Trend
stable
74
ChatGPT
94
77
Perplexity
89
74
Gemini
94
69
Claude
92
69
Grok
98

Key Details

Category
Hospital Operations & Real-Time Location Systems
Enterprise
Tier
Leader
Leader
Entity Type
brand
company

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.